NMPA Approval

Pramipexole Dihydrochloride Sustained Release Tablets

Approval Number

国药准字H20213752

Company深圳翰宇药业股份有限公司

Registration Date

September 30, 2021

Drug Information

Generic Name

盐酸普拉克索缓释片

Dosage Form

片剂

Strength

0.375mg（以C10H17N3S·2HCl·H2O计）

Drug Type

化学药品

Registration Date

September 30, 2021

Company Information

Applicant Company

Company Name深圳翰宇药业股份有限公司

Company Address

深圳市龙华区观澜高新园区观盛四路7号翰宇创新产业大楼

Manufacturing Company

Company Name深圳翰宇药业股份有限公司

Company Address

深圳市南山高新技术工业园区中区翰宇生物医药园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.